Category: Disclosures
[Disclosure] Samsung Biologics to Hold Extraordinary General Meeting on Oct 17 for Corporate Split Approval (207940)
[Disclosure] Alteogen (196170) to Receive USD 25,000,000 (Approx. KRW 35.05B) Milestone Technical Fee from MSD for ALT-B4
[Disclosure] SK Square (402340) Terminates KRW 100 Billion Treasury Share Acquisition Trust Contract Upon Expiration; 503,743 Shares Transferred to Corporate Account
[Disclosure] HPSP (403870) Board Resolves to Convene EGM on Nov 7; Nominates Former Intel SVP Choong-Heung Lee as Next CEO
[Disclosure] HPSP (403870) Announces CEO Transition: Yong-Woon Kim to Geun-Young Kim to Streamline Executive Execution
[Disclosure] HPSP (403870) Sets October 13 as Record Date to Finalize Voting Rights for Upcoming Extraordinary General Meeting